Ovarian cancer is one of the deadliest cancers affecting women. Every year, thousands of women around the world are diagnosed with this disease, and many cases are discovered too late for successful treatment.
One reason ovarian cancer is so dangerous is that it often develops silently. In the early stages, symptoms can be very mild or easily mistaken for common health problems such as bloating, stomach discomfort, or tiredness.
Because of this, many women do not know they have cancer until it has already spread throughout the body.
Among all types of ovarian cancer, one form is especially aggressive. It is called high-grade serous carcinoma, or HGSC. This cancer is responsible for most ovarian cancer deaths and is known for growing quickly and spreading early.
Even with surgery and chemotherapy, survival rates are still low. Many women diagnosed with advanced HGSC survive less than five years after diagnosis.
Now, scientists have made an important discovery that could help doctors find this deadly cancer earlier and possibly develop better treatments in the future. Researchers have identified the specific cells that may be responsible for starting this aggressive cancer.
The study was published in the journal Nature Communications and was led by Dr. Alexander Nikitin and his research team at Cornell University.
For many years, doctors believed that high-grade serous carcinoma probably did not begin inside the ovaries themselves. Instead, researchers suspected that it started in the fallopian tubes. These are the thin tubes that connect the ovaries to the uterus and help transport eggs during reproduction.
Although scientists strongly suspected the fallopian tubes were involved, they still did not know exactly which cells were responsible for starting the cancer. Finding the exact origin is very important because it could help doctors identify cancer much earlier, before it spreads.
In this new study, the researchers discovered that a special type of cell inside the fallopian tubes may be the true starting point of HGSC. These cells are known as pre-ciliated tubal epithelial cells.
These cells are in the middle of changing from stem cells into mature cells. Mature cells in the fallopian tubes often contain tiny hair-like structures called cilia. The cilia help move eggs and fluids through the tubes. Before these mature cilia fully form, the cells pass through a temporary stage known as the pre-ciliated stage.
In the past, many scientists thought stem cells themselves were the most likely source of ovarian cancer because stem cells can divide and grow rapidly. However, the new research showed something very different.
The scientists studied what happened when two important cancer-protecting genes, TP53 and RB1, were turned off. These genes normally help stop damaged cells from growing out of control. They are often called tumor suppressor genes because they protect the body against cancer.
When the researchers turned off these genes inside stem cells, the stem cells simply died. They did not become cancerous. But when the same genes were turned off inside the pre-ciliated cells, cancer began to grow.
To investigate further, the scientists used genetically modified mice whose genes closely resembled those found in humans. When TP53 and RB1 were disabled in the pre-ciliated cells of the mice, the animals rapidly developed high-grade ovarian cancer similar to human HGSC.
This finding strongly suggests that pre-ciliated cells may be the true origin of this deadly disease.
The researchers also made another important discovery. They found that a gene called Krt5 was highly active in these pre-ciliated cells. Because of this, Krt5 may become a useful biological marker for detecting early changes linked to ovarian cancer.
Biological markers are important tools in medicine because they can help doctors identify disease before symptoms appear. If future studies confirm these findings in humans, doctors may eventually be able to screen women for early warning signs of HGSC using markers like Krt5.
This could become a major breakthrough because early diagnosis greatly improves survival chances in many cancers. Right now, most ovarian cancers are found only after they have spread, making treatment far more difficult.
The study also gives researchers new ideas for possible treatments. Scientists already understand a great deal about how pre-ciliated cells develop and mature.
This process is called ciliogenesis. Because the biology of these cells is already well studied, researchers may eventually discover ways to interrupt the cancer process before tumors even form.
In the future, doctors might be able to target the specific cells or genes involved in the earliest stages of ovarian cancer. This could lead to personalized treatments for women who are at especially high risk of developing the disease.
Although the current research was carried out in mice, the researchers explained that human fallopian tubes are very similar. This means the findings are likely to apply to humans as well. However, more studies will still be needed to confirm the results in human tissues.
The discovery offers new hope in the fight against one of the deadliest cancers affecting women.
By finally identifying the likely starting point of high-grade serous carcinoma, scientists may now be much closer to developing earlier screening methods, better treatments, and possibly even ways to prevent the cancer from developing altogether.
If you care about cancer, please read studies about how to fight cancer with these anti-cancer superfoods ,and a berry that can prevent cancer, diabetes and obesity.
For more health information, please see recent studies about how to harness the power of anti-cancer foods and supplements, and cancer-fighting foods and recipes.
The research was published in Nature Communications.
Copyright © 2026 Knowridge Science Report. All rights reserved.
